FDA Drug Recalls

Recalls / Class II

Class IID-0253-2025

Product

Lorazepam 0.5 mg per 0.25 mL Oral Syringe, Delivers: 0.25 mL, Oral Concentrate, Rx Only, Refrigerate, Mfg by: PAI, Pkg by: Safecor Health, LLC, Columbus, OH 43204, NDC: a) 00054353244, b) 00121077001, c) 65162068784.

Affected lot / code info
Lot #s: a) 24210274, Exp 01/31/2025; 24401700, Exp 04/25/2025; b) 24251067, Exp 03/25/2025; 24421733, Exp 06/03/2025; c) 24261384, Exp 03/24/2025; 24370127, Exp 04/28/2025.

Why it was recalled

Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes.

Recalling firm

Firm
Safecor Health, LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
4060 Business Park Dr Ste B, Columbus, Ohio 43204-5047

Distribution

Quantity
3465 Oral Syringes
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2025-02-17
FDA classified
2025-03-05
Posted by FDA
2025-03-12
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0253-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls